Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.

Pim AartsJ C van HuijsteeH H van der ZeeKelsey R van StraalenE P Prens

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

Adalimumab initiated with clindamycin and rifampicin shows greater clinical effectiveness than adalimumab monotherapy. An important difference in effect was observed in the decrease of draining tunnels, addressing a serious limitation of adalimumab monotherapy.

Keyphrases

hidradenitis suppurativa
rheumatoid arthritis
juvenile idiopathic arthritis
randomized controlled trial
mycobacterium tuberculosis
systematic review
ulcerative colitis
combination therapy
pulmonary tuberculosis
open label
clinical trial
study protocol